XiteBio Technologies announces SoyRhizo 90-day on-seed window in Canada

XiteBio Technologies Inc. announces that it has received approval for the expanded use of XiteBio^® SoyRhizo^® up to 90 days on-seed in the Canadian market from the Canadian Food Inspection Agency (CFIA).

XiteBio^® SoyRhizo^®, the only premium soybean inoculant powered by AGPT^® (Advanced Growth Promoting Technology), now offers up to 90 days of on-seed viability. This provides retailers with greater opportunity when preparing for the upcoming 2021 growing season. XiteBio^® SoyRhizo^® has also been approved for use at a reduced rate of application, allowing for increased flexibility when being applied together with seed treatments.

Along with a two year product shelf life and an all-in-one packaged liquid formulation that does not require additional mixing, XiteBio^® SoyRhizo^® continues to enhance its ease of application. “We are driven to continually develop new ways to enhance the ease of use for our product lines”, says Bill Busby, Sales Manager at XiteBio. “This serves to strengthen the ease of use of SoyRhizo^® for retailers and growers”.

Featuring the revolutionary AGPT^®, XiteBio^® SoyRhizo^® works to invigorate the natural microflora in the soil while also adding fresh rhizobia for optimum nitrogen fixation. “Synergy is the key in AGPT^®. Working together with retailers and farmers allows us to keep developing unique ways to meet the needs of our farm customers”, explains Dr. Manas Banerjee, President & CEO of XiteBio. “This expansion of the label only adds more strength to our SoyRhizo^® offering”.

XiteBio^® SoyRhizo^®, a naturally occurring premium soybean inoculant powered by AGPT^®, enhances soybean performance and nodulation that maximizes soybean yield. Along with XiteBio^® PulseRhizo^® (premium inoculant for pea, lentil & faba bean), XiteBio^® SoyRhizo^® continues to be the outstanding options for the producers, dealers & distributors in North America. For full information on directions for use and seed treatment compatibility, please contact XiteBio Technologies Inc.